Mind Media is a leading player in the healthcare industry, specializing in medical technology for biofeedback, neurofeedback, EEG, and psychophysiological research. The company, established in 1992, has gained recognition for developing innovative NeuroTechnology for Health, qEEG, neurofeedback, and biofeedback. Their NeXus systems, known for being premium data acquisition systems, cater to various applications in self-regulation, real-time feedback training, and scientific research. Mind Media's commitment to quality is evident through their products, which are designed and developed under an ISO 13485 quality system, FDA registered, and EU certified. The company boasts an impressive track record with over 1700+ studies and scientific articles featuring its NeXus systems, indicating its strong foothold in the market. Mind Media's focus on empowering individuals to improve their health through NeuroTechnology and smart software reflects their dedication to facilitating healthcare professionals with innovative solutions. By leveraging real-time feedback training, their mission is to enable individuals to gain deeper insights into their health and learn autonomic self-regulation. This approach targets the underlying (psychosomatic) causes of health problems, signaling a shift towards a more proactive and preventative healthcare strategy. Overall, Mind Media's commitment to cutting-edge technology, coupled with its emphasis on empowering individuals to take charge of their health, positions the company as a promising player within the healthcare industry and an attractive prospect for potential venture capital investment.
There is no investment information
No recent news or press coverage available for Mind Media.